コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 All animals underwent invasive hemodynamic monitoring.
2 in 50 critically ill patients with advanced hemodynamic monitoring.
3 ction, including arterial catheters used for hemodynamic monitoring.
4 s to PCWP in ICU patients requiring invasive hemodynamic monitoring.
5 ed 40 patients in the ICU requiring invasive hemodynamic monitoring.
6 rdiopulmonary exercise testing with invasive hemodynamic monitoring.
7 cular preload in patients requiring invasive hemodynamic monitoring.
8 rdiopulmonary exercise testing with invasive hemodynamic monitoring.
9 ansesophageal echocardiography, and invasive hemodynamic monitoring.
10 equipment, and capability for full invasive hemodynamic monitoring.
11 went upright treadmill exercise testing with hemodynamic monitoring.
12 tobarbital (iv) and controlled by continuous hemodynamic monitoring.
13 e intensive care unit who underwent invasive hemodynamic monitoring.
14 the comparative trial, which did not require hemodynamic monitoring, 305 patients were randomly assig
16 unit (CICU), 223 patients (68%) had data on hemodynamic monitoring: 98 patients (63%) in the standar
17 ith these factors may require more intensive hemodynamic monitoring after CAS, including prolongation
20 anagement strategies that integrate invasive hemodynamic monitoring and early mechanical circulatory
22 rdiopulmonary exercise testing with invasive hemodynamic monitoring and first-pass radionuclide ventr
25 hemostasis management, intraoperative use of hemodynamic monitoring and renal replacement therapy, im
26 e implantation, a maximal exercise test with hemodynamic monitoring and respiratory gas analysis was
28 patients cannot be explained by noninvasive hemodynamic monitoring and the patient fails to respond
29 s were prescribed have a higher frequency of hemodynamic monitoring and use of sedative and neuromusc
30 ventilated pigs were prepared surgically for hemodynamic monitoring and were subjected to a right tho
31 n addition to exchange transfusion, invasive hemodynamic monitoring, and aggressive ventilatory suppo
36 ipient; intraoperative management, including hemodynamic monitoring; coagulation and potential crisis
37 rate variability measured with non-invasive hemodynamic monitoring consisting of bioimpedance cardia
38 Data on the clinical use of left atrial (LA) hemodynamic monitoring during MitraClip procedure are li
40 tions (mechanical ventilation, intravascular hemodynamic monitoring, feeding tube placement, tracheos
41 ts with severe heart failure felt to require hemodynamic monitoring for the optimization of medical t
42 raction (HFrEF) and to confirm the effect of hemodynamic-monitoring guided management on HF hospitali
45 pulmonary artery catheter during continuous hemodynamic monitoring in an intensive care unit setting
47 As in clinical trials, use of ambulatory hemodynamic monitoring in clinical practice is associate
48 ed sex differences in response to ambulatory hemodynamic monitoring in clinical practice using the Ca
50 udy examined the effectiveness of ambulatory hemodynamic monitoring in reducing HFH outside of the cl
52 olemia or cardiogenic shock), while invasive hemodynamic monitoring is recommended only for select pa
53 and recommendations may range from invasive hemodynamic monitoring, management of proper inotropic s
55 to conservative medical management, invasive hemodynamic monitoring may be helpful in guiding managem
56 d, in addition to continuous respiratory and hemodynamic monitoring.Measurements and Main Results: Th
57 rgoing cardiopulmonary exercise testing with hemodynamic monitoring (MGH-ExS [Massachusetts General H
59 tted to the intensive care unit for invasive hemodynamic monitoring of heart failure and if they had
60 ce (MR) imaging for noninvasive longitudinal hemodynamic monitoring of hepatic blood flow before and
61 ing is feasible for noninvasive longitudinal hemodynamic monitoring of hepatic blood flow before and
63 rdiopulmonary exercise testing with invasive hemodynamic monitoring on 104 patients with symptomatic
64 mproving Global Outcome guidelines: advanced hemodynamic monitoring, optimisation of volume status an
65 Thirty ventilated patients with invasive hemodynamic monitoring (PiCCO-2; Pulsion Medical Systems
67 sing simple bedside calculations (functional hemodynamic monitoring); prior physiologic data of simil
70 edical therapy and advances such as invasive hemodynamic monitoring remain challenging to manage.
73 riate resuscitation fluids, vasopressors and hemodynamic monitoring systems to maximize maternal and
74 locking agents used, mechanical ventilation, hemodynamic monitoring, Therapeutic Intervention Scoring
76 ed resuscitation from shock using functional hemodynamic monitoring using invasive monitoring (ReFit1
78 resonance imaging with simultaneous invasive hemodynamic monitoring, we sought to quantify the steps
79 travenous treatment for acute HF and central hemodynamic monitoring were randomized to 24-h intraveno
80 atients with CS can be guided effectively by hemodynamic monitoring with a pulmonary artery catheter